1. Home
  2. KVAC vs ALEC Comparison

KVAC vs ALEC Comparison

Compare KVAC & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KVAC
  • ALEC
  • Stock Information
  • Founded
  • KVAC 2021
  • ALEC 2013
  • Country
  • KVAC United States
  • ALEC United States
  • Employees
  • KVAC N/A
  • ALEC N/A
  • Industry
  • KVAC
  • ALEC Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KVAC
  • ALEC Health Care
  • Exchange
  • KVAC Nasdaq
  • ALEC Nasdaq
  • Market Cap
  • KVAC 120.9M
  • ALEC 101.1M
  • IPO Year
  • KVAC 2023
  • ALEC 2019
  • Fundamental
  • Price
  • KVAC N/A
  • ALEC $0.92
  • Analyst Decision
  • KVAC
  • ALEC Buy
  • Analyst Count
  • KVAC 0
  • ALEC 7
  • Target Price
  • KVAC N/A
  • ALEC $4.10
  • AVG Volume (30 Days)
  • KVAC 689.0
  • ALEC 638.9K
  • Earning Date
  • KVAC 01-01-0001
  • ALEC 05-07-2025
  • Dividend Yield
  • KVAC N/A
  • ALEC N/A
  • EPS Growth
  • KVAC 197.31
  • ALEC N/A
  • EPS
  • KVAC 0.41
  • ALEC N/A
  • Revenue
  • KVAC N/A
  • ALEC $100,558,000.00
  • Revenue This Year
  • KVAC N/A
  • ALEC N/A
  • Revenue Next Year
  • KVAC N/A
  • ALEC $376.51
  • P/E Ratio
  • KVAC $27.21
  • ALEC N/A
  • Revenue Growth
  • KVAC N/A
  • ALEC 3.60
  • 52 Week Low
  • KVAC $10.47
  • ALEC $0.87
  • 52 Week High
  • KVAC $11.25
  • ALEC $6.78
  • Technical
  • Relative Strength Index (RSI)
  • KVAC 72.19
  • ALEC 33.58
  • Support Level
  • KVAC $11.20
  • ALEC $0.87
  • Resistance Level
  • KVAC $11.14
  • ALEC $1.09
  • Average True Range (ATR)
  • KVAC 0.00
  • ALEC 0.10
  • MACD
  • KVAC 0.00
  • ALEC 0.00
  • Stochastic Oscillator
  • KVAC 100.00
  • ALEC 12.25

About KVAC Keen Vision Acquisition Corporation

Keen Vision Acquisition Corp is a blank check company.

About ALEC Alector Inc.

Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.

Share on Social Networks: